The EXACT Trial Gives Hope for Patients with Refractory Angina: Updates from #SCAI2024

For patients diagnosed with refractory angina, the road ahead is often a difficult quality of life with few treatment options. But as Dr. Thomas Povsic, MD, PhD, FSCAI, details in this SCAI TV interview, late-breaking research presented at #SVCAI2024 - the EXACT Trial - shows promise by encouraging the growth of new blood vessels using Vascular Endothelial Growth Factor (VEGF).